Get started
Author

Alasdair P. J. Parker

Observed names: A P J Parker, A P Parker, A Parker, A. P. J. Parker, A. Parker, Alasdair P J Parker, Alasdair P Parker, Alasdair P. Parker, Alasdair P.J. Parker, Alasdair PJ Parker, Alasdair PJ. Parker, Alasdair Parker, Parker, Alasdair, Soo-Mi Park
Observed institutions: Centre National de la Recherche Scientifique, Guy's Hospital, St Thomas' Hospital, Mayo Clinic, Inserm, University of Cambridge, Great Ormond Street Hospital, Cambridge University Hospitals NHS Foundation Trust, Wellcome Sanger Institute, Institut de génétique et de biologie moléculaire et cellulaire, St. Thomas Hospital, Addenbrooke's Hospital, Hôpital d'Hautepierre, University College London, Université de Strasbourg
ORCID: 0000-0002-8768-2686
Observed ORCID: 0000-0002-8768-2686
OpenAlex ID: A5006079808
Comprehensive Rare Variant Analysis via Whole-Genome Sequencing to Determine the Molecular Pathology of Inherited Retinal Disease
2016 · Keren J. Carss, Gavin Arno, et al. · The American Journal of Human Genetics · 463
Childhood arterial ischaemic stroke incidence, presenting features, and risk factors: a prospective population-based study
2013 · Andrew A Mallick, Vijeya Ganesan, et al. · The Lancet Neurology · 380
Whole-genome sequencing of a sporadic primary immunodeficiency cohort
2020 · James E. D. Thaventhiran, Hana Lango Allen, et al. · Nature · 240
PDF
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial
2021 · Anthony Marson, Girvan Burnside, et al. · The Lancet · 221
PDF
The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial
2021 · Anthony Marson, Girvan Burnside, et al. · The Lancet · 207
PDF
Investigating microcephaly
2013 · C. G. Woods, A. Parker · Archives of Disease in Childhood · 173
PDF
Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial
2018 · Finbar J K O'Callaghan, Stuart W Edwards, et al. · The Lancet Child & Adolescent Health · 168
PDF
Vagal Nerve Stimulation in Epileptic Encephalopathies
1999 · Alasdair P. J. Parker, Charles E. Polkey, et al. · PEDIATRICS · 168
Recommendations for the detection and diagnosis of Niemann-Pick disease type C
2017 · Marc C. Patterson, Peter Clayton, et al. · Neurology Clinical Practice · 162
PDF
Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension
2017 · Charaka Hadinnapola, Marta Bleda, et al. · Circulation · 147
Diagnostic delays in paediatric stroke
2014 · Andrew A Mallick, Vijeya Ganesan, et al. · Journal of Neurology Neurosurgery & Psychiatry · 126
Everolimus for treatment-refractory seizures in TSC
2018 · David N. Franz, John A. Lawson, et al. · Neurology Clinical Practice · 109
PDF
Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data
2018 · James H. R. Farmery, Mike L. Smith, et al. · Scientific Reports · 88
PDF
Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes
2018 · James Whitworth, Philip S. Smith, et al. · The American Journal of Human Genetics · 68
PDF
Interaction of cannabidiol with other antiseizure medications: A narrative review
2020 · Christopher G.S. Gilmartin, Zoya Dowd, et al. · Seizure · 65
PDF
Outcome and recurrence 1 year after pediatric arterial ischemic stroke in a population‐based cohort
2016 · Andrew A. Mallick, Vijeya Ganesan, et al. · Annals of Neurology · 62
PDF
Phenotypic and genetic spectrum of epilepsy with myoclonic atonic seizures
2020 · Shan Tang, Laura Addis, et al. · Epilepsia · 58
PDF
Movement disorder emergencies in childhood
2011 · F.J. Kirkham, P. Haywood, et al. · European Journal of Paediatric Neurology · 58
Inappropriate use of carbamazepine and vigabatrin in typical absence seizures
1998 · A P J Parker, A. Agathonikou, et al. · Developmental Medicine & Child Neurology · 56
PDF
Classic ketogenic diet versus further antiseizure medicine in infants with drug-resistant epilepsy (KIWE): a UK, multicentre, open-label, randomised clinical trial
2023 · Natasha E Schoeler, Louise Marston, et al. · The Lancet Neurology · 55
PDF
The UK guidelines for management and surveillance of Tuberous Sclerosis Complex
2018 · S Amin, J C Kingswood, et al. · QJM · 52
PDF
Clinical features of childhood‐onset paroxysmal kinesigenic dyskinesia with PRRT 2 gene mutations
2013 · Laura Silveira‐Moriyama, Alice R Gardiner, et al. · Developmental Medicine & Child Neurology · 49
PDF
Genome annotation for clinical genomic diagnostics: strengths and weaknesses
2017 · Charles A. Steward, Alasdair P. J. Parker, et al. · Genome Medicine · 48
PDF
Vigabatrin aggravates absences and absence status
1997 · C. P. Panayiotopoulos, A. Agathonikou, et al. · Neurology · 45
De Novo Truncating Mutations in WASF1 Cause Intellectual Disability with Seizures
2018 · Yoko Ito, Keren J. Carss, et al. · The American Journal of Human Genetics · 42
PDF
Works count: 89
Citation count: 3,670
H-index: 27
I10-index: 38
Year
Topic
Type